Compounds > tecastemizole
Page last updated: 2024-09-03

tecastemizole and chlorpromazine

tecastemizole has been researched along with chlorpromazine in 5 studies

Compound Research Comparison

Studies
(tecastemizole)		Trials
(tecastemizole)		Recent Studies (post-2010)
(tecastemizole)		Studies
(chlorpromazine)		Trials
(chlorpromazine)		Recent Studies (post-2010) (chlorpromazine)
180317,497777739

Protein Interaction Comparison

ProteinTaxonomytecastemizole (IC50)chlorpromazine (IC50)
Adenylate cyclase type 1 Rattus norvegicus (Norway rat)1.3
Spike glycoproteinBetacoronavirus England 19.51
Replicase polyprotein 1abBetacoronavirus England 19.51
Solute carrier family 22 member 1 Homo sapiens (human)4.3
Transmembrane protease serine 2Homo sapiens (human)9.51
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)0.85
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)3.4
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.0052
Potassium channel subfamily K member 2Homo sapiens (human)2.7
Tyrosine-protein kinase FynHomo sapiens (human)8.68
Procathepsin LHomo sapiens (human)9.51
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.019
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.652
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.149
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.025
Alpha-2A adrenergic receptorHomo sapiens (human)0.352
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus9.51
Replicase polyprotein 1abHuman coronavirus 229E9.51
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus9.51
Calmodulin-1Homo sapiens (human)7.63
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 29.51
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.083
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)5.8275
D(2) dopamine receptorHomo sapiens (human)0.0142
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.031
Alpha-2B adrenergic receptorHomo sapiens (human)0.026
Alpha-2C adrenergic receptorHomo sapiens (human)0.374
DRattus norvegicus (Norway rat)0.1414
D(3) dopamine receptorRattus norvegicus (Norway rat)0.0416
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)4.685
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)1.4791
D(2) dopamine receptorBos taurus (cattle)0.5328
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.206
D(1A) dopamine receptorHomo sapiens (human)0.225
D(4) dopamine receptorHomo sapiens (human)1.365
Adenylate cyclase type 3Rattus norvegicus (Norway rat)1.3
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)1.4791
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)1.4791
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.031
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.019
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)1.4791
Histamine H2 receptorHomo sapiens (human)2.626
Alpha-1D adrenergic receptorHomo sapiens (human)0.004
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.0416
Adenylate cyclase type 2Rattus norvegicus (Norway rat)1.3
Adenylate cyclase type 4Rattus norvegicus (Norway rat)1.3
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0036
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0052
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)4.685
Trypanothione reductaseTrypanosoma cruzi5.8
D(4) dopamine receptorRattus norvegicus (Norway rat)0.0416
Sodium-dependent serotonin transporterHomo sapiens (human)0.0795
Melanocortin receptor 5Homo sapiens (human)7.617
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C4.5
Histamine H1 receptorHomo sapiens (human)0.0145
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.3
D(3) dopamine receptorHomo sapiens (human)0.012
Sodium channel protein type 1 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 4 subunit alphaHomo sapiens (human)4.3
Adenylate cyclase type 8Rattus norvegicus (Norway rat)1.3
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.126
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.031
5-hydroxytryptamine receptor 6Homo sapiens (human)0.057
Spike glycoproteinSevere acute respiratory syndrome-related coronavirus9.51
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0365
Calmodulin Bos taurus (cattle)2.5
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)1.3
Sodium channel protein type 7 subunit alphaHomo sapiens (human)4.3
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)3.4
Sodium-dependent dopamine transporter Homo sapiens (human)2.643
Adenylate cyclase type 6Rattus norvegicus (Norway rat)1.3
Adenylate cyclase type 5Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.85
Aldehyde oxidaseHomo sapiens (human)0.57
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.9602
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)0.85
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)3.4
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)3.4
Sodium channel protein type 5 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)0.85
Sodium channel protein type 9 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)1.3
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)5.8275
Adenylyl cyclase 7 Rattus norvegicus (Norway rat)1.3
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)0.85
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)1.3
DBos taurus (cattle)0.646
Sodium channel protein type 2 subunit alphaHomo sapiens (human)4.3
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.451
Angiotensin-converting enzyme 2 Homo sapiens (human)9.51
Sodium channel protein type 3 subunit alphaHomo sapiens (human)4.3
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)1.3
Sodium channel protein type 11 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 8 subunit alphaHomo sapiens (human)4.3
Sodium channel protein type 10 subunit alphaHomo sapiens (human)4.3

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M1
Keserü, GM1
Li, J; Rajamani, R; Reynolds, CH; Tounge, BA1
Jia, L; Sun, H1
Caron, G; Ermondi, G; Visentin, S1

Other Studies

5 other study(ies) available for tecastemizole and chlorpromazine

ArticleYear
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
    Journal of medicinal chemistry, 2002, Aug-29, Volume: 45, Issue:18

    Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship

2002
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship

2003
A two-state homology model of the hERG K+ channel: application to ligand binding.
    Bioorganic & medicinal chemistry letters, 2005, Mar-15, Volume: 15, Issue:6

    Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Ligands; Models, Biological; Models, Molecular; Potassium Channels, Voltage-Gated; Protein Binding; Protein Conformation

2005
Support vector machines classification of hERG liabilities based on atom types.
    Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve

2008
GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:5

    Topics: Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Potassium Channel Blockers; Quantitative Structure-Activity Relationship

2009